According to a new report published by Allied Market Research, titled, โ€œNeoantigen Market: Global Opportunity Analysis and Industry Forecast, 2021-2030โ€ Neoantigen is a protein that forms on the cancerous cells as a result on mutations in the tumorous DNA. They are thus used in development on vaccines and immunotherapies against cancer cells. Neoantigens are recognized in the body by neoantigen-specific T cell receptors (TCRs). Neoantigen-based vaccines and target therapies have shown promising results in various clinical trials, owing to the fact that they can be recognized as non-self/foreign and germline by the hostโ€™s immune system. Neoantigens find huge significance in cancer immunoediting. It is a technique used to establish dual roles of immune system with respect to tumor growth.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐๐ƒ๐… ๐๐จ๐ฎ๐œ๐ก๐ž๐ซ: https://www.alliedmarketresearch.com/request-sample/13732

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global neoantigens market.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/purchase-enquiry/13732

North America is anticipated to show dominance in neoantigen market owing to rising cases of cancer in the region coupled with growing demand of development of advanced treatment mechanisms.

BioNTech S.E. recently developed and launched individualized vaccine against cancer (IVAC) platform that helps in production of customized neoantigen vaccines.

Further, Genocea Biosciences developed ATLAS platform for development of neoantigen vaccines. It makes use of an ex-vivo method to treat melanoma, carcinoma, and lung cancers.

๐Š๐ž๐ฒ ๐๐ž๐ง๐ž๐Ÿ๐ข๐ญ๐ฌ:

  • This study presents the analytical depiction of the neoantigens industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the neoantigens market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the neoantigens growth scenario.
  • Porterโ€™s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/request-for-customization/13732

Key Market Players

  • Achilles Therapeutics plc
  • Advaxis, Inc.
  • Frame Cancer Therapeutics
  • Genocea
  • Gradalis, Inc.
  • Gritstone Oncology
  • Immunicum AB
  • Medigene AG
  • Ziopharm Oncology, Inc.
  • Moderna, Inc.
  • Merck & Co. Inc

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

North America and Europe Menstrual Cup Market: https://www.alliedmarketresearch.com/north-america-and-europe-menstrual-cup-market-A06126

Surgical Robotic System Market: https://www.alliedmarketresearch.com/surgical-robotic-systems-market-A06827

Surgical Drains Market: https://www.alliedmarketresearch.com/wound-drainage-surgical-drains-market-A07517

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *